A71 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 206 EUR 0.98% Market Closed

Market Cap: €11.8B

A	Ascendis Pharma A/S F:A71	DK
	Komercni Banka as PSE:KOMB	CZ
I	Industrial and Commercial Bank of China Ltd F:ICK	CN
	Xiaomi Corp F:3CP	CN
A	Adani Ports and Special Economic Zone Ltd BSE:532921	IN
	Dusk Group Ltd F:6EA	AU
	Italian Wine Brands S.P.A. MIL:IWB	IT
L	Lenzing AG DUS:LEN	AT
	Dai-ichi Life Holdings Inc OTC:DCNSF	JP
C	Ctp NV PSE:CTPNV	NL
D	Deutsche Boerse AG SWB:DB1	DE
	MedPlus Health Services Ltd NSE:MEDPLUS	IN
S	State Bank of India F:SID	IN

Profitability Summary

Ascendis Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

85%

Gross Margin is Increasing

80% > 89%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-133%

Operating Margin is Increasing

-484% > -1%

Exceptional Net Margin

57%

Negative 3Y Average Net Margin

-149%

Net Margin is Increasing

-511% > 57%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-126%

Free Cash Flow Margin is Increasing

-461% > 5%

Exceptional ROE

333%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-95%

ROIC is Increasing

-205% > 2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.